Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening

Conclusions: Triennial screening with mt-sDNA resulted in better clinical outcomes at a lower cost compared with the modeled blood-based test even at perfect adherence, supporting application of blood-based tests only as a secondary screening option.PMID:38686394 | DOI:10.1080/13696998.2024.2349467
Source: Journal of Medical Economics - Category: Health Management Authors: Source Type: research